Diabetes

Latest News

Lilly Slashed Its Insulin Prices. Will Sanofi and Novo Nordisk Do the Same?
Lilly Slashed Its Insulin Prices. Will Sanofi and Novo Nordisk Do the Same?

March 2nd 2023

Patient groups and lawmakers such as Sen. Bernie Sanders want Sanofi and Novo Nordisk to follow Eli Lilly's example and reduce the prices of their insulin products. Both companies said they already have programs that bring down the cost.

Some Mental Health Conditions Add to the Atrial Fibrillation Risk from Diabetes, Study Finds
Some Mental Health Conditions Add to the Atrial Fibrillation Risk from Diabetes, Study Finds

December 9th 2022

  Dialing Up Telehealth to Comprehensive Level Makes it More Effective: JAMA Internal Medicine Study
Dialing Up Telehealth to Comprehensive Level Makes it More Effective: JAMA Internal Medicine Study

July 28th 2022

Tirzepatide Gets Middling Grade From ICER
Tirzepatide Gets Middling Grade From ICER

January 6th 2022

ICER: Initial Evidence Shows a Wide Range of Estimates for Cost-effectiveness of Tirzepatide
ICER: Initial Evidence Shows a Wide Range of Estimates for Cost-effectiveness of Tirzepatide

November 9th 2021

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.